CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Seeking Alpha Healthcare
Original article

Myriad Genetics in record sell-off after Q1 miss

EarningsnegativeNegative
AI Analysis

Summary

Myriad Genetics experienced a significant sell-off following a Q1 earnings miss. The stock decline reflects investor disappointment with the company's quarterly financial performance.

Outcome Details

Q1 earnings miss

Importance:5/10
Sentiment:
-0.80
earningsQ1stock_declinemiss
Related Companies

Read the original article

Published by Seeking Alpha Healthcare on May 6, 2026 6:19 PM

Read Original